These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34439014)

  • 21. Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.
    Li M; Neoh KG; Xu L; Yuan L; Leong DT; Kang ET; Chua KL; Hsu LY
    Pharm Res; 2016 May; 33(5):1161-74. PubMed ID: 26792570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Antibacterial Molecule(s) from Animals Living in Polluted Environments.
    Winnie FYM; Siddiqui R; Sagathevan K; Khan NA
    Curr Pharm Biotechnol; 2020; 21(5):425-437. PubMed ID: 31577204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of distribution and drug resistance of pathogens isolated from 159 patients with catheter-related bloodstream infection in burn intensive care unit].
    Luo XQ; Gong YL; Zhang C; Liu MX; Shi YL; Peng YZ; Li N
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):24-31. PubMed ID: 32023714
    [No Abstract]   [Full Text] [Related]  

  • 27. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
    Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of antibacterial conjugates using sulfamethoxazole with monocyclic terpenes: A systematic medicinal chemistry based computational approach.
    Swain SS; Paidesetty SK; Padhy RN
    Comput Methods Programs Biomed; 2017 Mar; 140():185-194. PubMed ID: 28254074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Potency of
    Oliva A; Costantini S; De Angelis M; Garzoli S; Božović M; Mascellino MT; Vullo V; Ragno R
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30304862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRJP1-containing glycoproteins isolated from honey, a novel antibacterial drug candidate with broad spectrum activity against multi-drug resistant clinical isolates.
    Brudzynski K; Sjaarda C; Lannigan R
    Front Microbiol; 2015; 6():711. PubMed ID: 26217333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts.
    Elisha IL; Botha FS; McGaw LJ; Eloff JN
    BMC Complement Altern Med; 2017 Feb; 17(1):133. PubMed ID: 28241818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal properties of moxifloxacin and post-antibiotic effect.
    Boswell FJ; Andrews JM; Wise R; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():43-9. PubMed ID: 10382875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):84-92. PubMed ID: 15828175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
    Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic activities of cefpirome against fresh clinical isolates resistant to multiple drugs].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1994 Feb; 47(2):143-60. PubMed ID: 8151908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells.
    Dharmaratne MPJ; Manoraj A; Thevanesam V; Ekanayake A; Kumar NS; Liyanapathirana V; Abeyratne E; Bandara BMR
    BMC Complement Altern Med; 2018 Dec; 18(1):325. PubMed ID: 30526562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.